Novartis Taps Relation To Boost AI-Driven Drug Discovery In Immuno-Dermatology

 
• By Sushmita Panda
  
Extreme close up of test tubes filled with pills and drugs.
Relation is a technology-enabled biopharmaceutical company developing medicines across immunology, metabolic and bone diseases. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business